|
1
|
Aasen T, Mesnil M, Naus CC, Lampe PD and
Laird DW: Gap junctions and cancer: Communicating for 50 years. Nat
Rev Cancer. 16:775–788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Falk MM: Connexin-specific distribution
within gap junctions revealed in living cells. J Cell Sci.
113:4109–4120. 2000.PubMed/NCBI
|
|
3
|
Goodenough DA and Paul DL: Gap junctions.
Cold Spring Harb Perspect Biol. 1:a0025762009. View Article : Google Scholar :
|
|
4
|
Loewenstein WR and Kanno Y: Intercellular
communication and the control of tissue growth: Lack of
communication between cancer cells. Nature. 209:1248–1249. 1966.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loewenstein WR and Kanno Y: Intercellular
communication and tissue growth. I. Cancerous growth. J Cell Biol.
33:225–234. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fentiman IS and Taylor-Papadimitriou J:
Cultured human breast cancer cells lose selectivity in direct
intercellular communication. Nature. 269:156–158. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kańczuga-Koda L, Sulkowska M, Koda M,
Reszeć J, Famulski W, Baltaziak M and Sulkowski S: Expression of
connexin 43 in breast cancer in comparison with mammary dysplasia
and the normal mammary gland. Folia Morphol (Warsz). 62:439–442.
2003.
|
|
8
|
Kanczuga-Koda L, Sulkowska M, Koda M,
Rutkowski R and Sulkowski S: Increased expression of gap junction
protein-connexin 32 in lymph node metastases of human ductal breast
cancer. Folia Histochem Cytobiol. 45(Suppl 1): S175–S180. 2007.
|
|
9
|
Kanczuga-Koda L, Sulkowski S, Lenczewski
A, Koda M, Wincewicz A, Baltaziak M and Sulkowska M: Increased
expression of connexins 26 and 43 in lymph node metastases of
breast cancer. J Clin Pathol. 59:429–433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanczuga-Koda L, Sulkowski S, Tomaszewski
J, Koda M, Sulkowska M, Przystupa W, Golaszewska J and Baltaziak M:
Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein
in breast cancer. Oncol Rep. 14:325–329. 2005.PubMed/NCBI
|
|
11
|
Carystinos GD, Bier A and Batist G: The
role of connexin-mediated cell-cell communication in breast cancer
metastasis. J Mammary Gland Biol Neoplasia. 6:431–440. 2001.
View Article : Google Scholar
|
|
12
|
Elzarrad MK, Haroon A, Willecke K,
Dobrowolski R, Gillespie MN and Al-Mehdi AB: Connexin-43
upregulation in micrometastases and tumor vasculature and its role
in tumor cell attachment to pulmonary endothelium. BMC Med.
6:202008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kandouz M and Batist G: Gap junctions and
connexins as therapeutic targets in cancer. Expert Opin Ther
Targets. 14:681–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kapoor P, Saunders MM, Li Z, Zhou Z,
Sheaffer N, Kunze EL, Samant RS, Welch DR and Donahue HJ: Breast
cancer metastatic potential: correlation with increased heterotypic
gap junctional intercellular communication between breast cancer
cells and osteoblastic cells. Int J Cancer. 111:693–697. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Zhou Z and Donahue HJ: Alterations
in Cx43 and OB-cadherin affect breast cancer cell metastatic
potential. Clin Exp Metastasis. 25:265–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Zhou Z, Welch DR and Donahue HJ:
Expressing connexin 43 in breast cancer cells reduces their
metastasis to lungs. Clin Exp Metastasis. 25:893–901. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McLachlan E, Shao Q and Laird DW:
Connexins and gap junctions in mammary gland development and breast
cancer progression. J Membr Biol. 218:107–121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Plante I, Stewart MK, Barr K, Allan AL and
Laird DW: Cx43 suppresses mammary tumor metastasis to the lung in a
Cx43 mutant mouse model of human disease. Oncogene. 30:1681–1692.
2011. View Article : Google Scholar
|
|
19
|
Pollmann MA, Shao Q, Laird DW and Sandig
M: Connexin 43 mediated gap junctional communication enhances
breast tumor cell diapedesis in culture. Breast Cancer Res.
7:R522–R534. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saunders MM, Seraj MJ, Li Z, Zhou Z,
Winter CR, Welch DR and Donahue HJ: Breast cancer metastatic
potential correlates with a breakdown in homospecific and
heterospecific gap junctional intercellular communication. Cancer
Res. 61:1765–1767. 2001.PubMed/NCBI
|
|
21
|
Shishido SN, Delahaye A, Beck A and Nguyen
TA: The anticancer effect of PQ1 in the MMTV-PyVT mouse model. Int
J Cancer. 134:1474–1483. 2014. View Article : Google Scholar :
|
|
22
|
Jamieson S, Going JJ, D'Arcy R and George
WD: Expression of gap junction proteins connexin 26 and connexin 43
in normal human breast and in breast tumours. J Pathol. 184:37–43.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Laird DW, Fistouris P, Batist G, Alpert L,
Huynh HT, Carystinos GD and Alaoui-Jamali MA: Deficiency of
connexin43 gap junctions is an independent marker for breast
tumors. Cancer Res. 59:4104–4110. 1999.PubMed/NCBI
|
|
24
|
Monaghan P, Clarke C, Perusinghe NP, Moss
DW, Chen XY and Evans WH: Gap junction distribution and connexin
expression in human breast. Exp Cell Res. 223:29–38. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilgenbus KK, Kirkpatrick CJ, Knuechel R,
Willecke K and Traub O: Expression of Cx26, Cx32 and Cx43 gap
junction proteins in normal and neoplastic human tissues. Int J
Cancer. 51:522–529. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Teleki I, Szasz AM, Maros ME, Gyorffy B,
Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A and Krenacs T:
Correlations of differentially expressed gap junction connexins
Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and
prognosis. PLoS One. 9:e1125412014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teleki I, Krenacs T, Szasz MA, Kulka J,
Wichmann B, Leo C, Papassotiropoulos B, Riemenschnitter C, Moch H
and Varga Z: The potential prognostic value of connexin 26 and 46
expression in neoadjuvant-treated breast cancer. BMC Cancer.
13:502013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stoletov K, Strnadel J, Zardouzian E,
Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR
and Klemke RL: Role of connexins in metastatic breast cancer and
melanoma brain colonization. J Cell Sci. 126:904–913. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pozzi A, Risek B, Kiang DT, Gilula NB and
Kumar NM: Analysis of multiple gap junction gene products in the
rodent and human mammary gland. Exp Cell Res. 220:212–219. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shipitsin M, Campbell LL, Argani P,
Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T,
Serebryiskaya T, Beroukhim R, Hu M, et al: Molecular definition of
breast tumor heterogeneity. Cancer Cell. 11:259–273. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krutovskikh VA, Piccoli C and Yamasaki H:
Gap junction intercellular communication propagates cell death in
cancerous cells. Oncogene. 21:1989–1999. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garfield RE, Puri CP and Csapo AI:
Endocrine, structural, and functional changes in the uterus during
premature labor. Am J Obstet Gynecol. 142:21–27. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garfield RE, Sims S and Daniel EE: Gap
junctions: Their presence and necessity in myometrium during
parturition. Science. 198:958–960. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hendrix EM, Mao SJ, Everson W and Larsen
WJ: Myometrial connexin 43 trafficking and gap junction assembly at
term and in preterm labor. Mol Reprod Dev. 33:27–38. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Risek B, Guthrie S, Kumar N and Gilula NB:
Modulation of gap junction transcript and protein expression during
pregnancy in the rat. J Cell Biol. 110:269–282. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Clarke MF and Fuller M: Stem cells and
cancer: Two faces of eve. Cell. 124:1111–1115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lynch MD, Cariati M and Purushotham AD:
Breast cancer, stem cells and prospects for therapy. Breast Cancer
Res. 8:2112006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Polyak K and Hahn WC: Roots and stems:
Stem cells in cancer. Nat Med. 12:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wicha MS, Liu S and Dontu G: Cancer stem
cells: An old idea - a paradigm shift. Cancer Res. 66:1883–1890;
discussion 1895–6. 2006. View Article : Google Scholar
|
|
40
|
Park SY, Lee HE, Li H, Shipitsin M, Gelman
R and Polyak K: Heterogeneity for stem cell-related markers
according to tumor subtype and histologic stage in breast cancer.
Clin Cancer Res. 16:876–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Solan JL and Lampe PD: Connexin43
phosphorylation: Structural changes and biological effects. Biochem
J. 419:261–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gould VE, Mosquera JM, Leykauf K, Gattuso
P, Dürst M and Alonso A: The phosphorylated form of connexin43 is
up-regulated in breast hyperplasias and carcinomas and in their
neoformed capillaries. Hum Pathol. 36:536–545. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Warn-Cramer BJ, Lampe PD, Kurata WE,
Kanemitsu MY, Loo LW, Eckhart W and Lau AF: Characterization of the
mitogen-activated protein kinase phosphorylation sites on the
connexin-43 gap junction protein. J Biol Chem. 271:3779–3786. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Warn-Cramer BJ, Cottrell GT, Burt JM and
Lau AF: Regulation of connexin-43 gap junctional intercellular
communication by mitogen-activated protein kinase. J Biol Chem.
273:9188–9196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Laird DW: The life cycle of a connexin:
Gap junction formation, removal, and degradation. J Bioenerg
Biomembr. 28:311–318. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leykauf K, Dürst M and Alonso A:
Phosphorylation and subcellular distribution of connexin43 in
normal and stressed cells. Cell Tissue Res. 311:23–30. 2003.
View Article : Google Scholar
|
|
47
|
Melchheier I, von Montfort C, Stuhlmann D,
Sies H and Klotz LO: Quinone-induced Cdc25A inhibition causes
ERK-dependent connexin phosphorylation. Biochem Biophys Res Commun.
327:1016–1023. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee KM, Kwon JY, Lee KW and Lee HJ:
Ascorbic acid 6-palmitate suppresses gap-junctional intercellular
communication through phosphorylation of connexin 43 via activation
of the MEK-ERK pathway. Mutat Res. 660:51–56. 2009. View Article : Google Scholar
|
|
49
|
Riquelme MA, Burra S, Kar R, Lampe PD and
Jiang JX: Mitogen-activated protein kinase (MAPK) activated by
prostaglandin E2 phosphorylates connexin 43 and closes osteocytic
hemichannels in response to continuous flow shear stress. J Biol
Chem. 290:28321–28328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kang NJ, Lee KM, Kim JH, Lee BK, Kwon JY,
Lee KW and Lee HJ: Inhibition of gap junctional intercellular
communication by the green tea polyphenol (-)-epigallocatechin
gallate in normal rat liver epithelial cells. J Agric Food Chem.
56:10422–10427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Abdelmohsen K, Sauerbier E, Ale-Agha N,
Beier J, Walter P, Galban S, Stuhlmann D, Sies H and Klotz LO:
Epidermal growth factor- and stress-induced loss of gap junctional
communication is mediated by ERK-1/ERK-2 but not ERK-5 in rat liver
epithelial cells. Biochem Biophys Res Commun. 364:313–317. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Munoz JL, Rodriguez-Cruz V, Greco SJ,
Ramkissoon SH, Ligon KL and Rameshwar P: Temozolomide resistance in
glioblastoma cells occurs partly through epidermal growth factor
receptor-mediated induction of connexin 43. Cell Death Dis.
5:e11452014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dubé E, Dufresne J, Chan PT and Cyr DG:
Epidermal growth factor regulates connexin 43 in the human
epididymis: Role of gap junctions in azoospermia. Hum Reprod.
27:2285–2296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Evans WH, Bultynck G and Leybaert L:
Manipulating connexin communication channels: Use of
peptidomimetics and the translational outputs. J Membr Biol.
245:437–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
De Vuyst E, Boengler K, Antoons G, Sipido
KR, Schulz R and Leybaert L: Pharmacological modulation of
connexin-formed channels in cardiac pathophysiology. Br J
Pharmacol. 163:469–483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grek CL, Rhett JM, Bruce JS, Abt MA,
Ghatnekar GS and Yeh ES: Targeting connexin 43 with α-connexin
carboxyl-terminal (ACT1) peptide enhances the activity of the
targeted inhibitors, tamoxifen and lapatinib, in breast cancer:
Clinical implication for ACT1. BMC Cancer. 15:2962015. View Article : Google Scholar
|
|
57
|
Fosgerau K and Hoffmann T: Peptide
therapeutics: Current status and future directions. Drug Discov
Today. 20:122–128. 2015. View Article : Google Scholar
|
|
58
|
Leithe E, Mesnil M and Aasen T: The
connexin 43 C-terminus: A tail of many tales. Biochim Biophys Acta.
2017 May;16:2017.Epub ahead of print. View Article : Google Scholar
|
|
59
|
Moorby C and Patel M: Dual functions for
connexins: Cx43 regulates growth independently of gap junction
formation. Exp Cell Res. 271:238–248. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang YW, Nakayama K, Nakayama K and
Morita I: A novel route for connexin 43 to inhibit cell
proliferation: Negative regulation of S-phase kinase-associated
protein (Skp 2). Cancer Res. 63:1623–1630. 2003.PubMed/NCBI
|
|
61
|
Behrens J, Kameritsch P, Wallner S, Pohl U
and Pogoda K: The carboxyl tail of Cx43 augments p38 mediated cell
migration in a gap junction-independent manner. Eur J Cell Biol.
89:828–838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hebert C and Stains JP: An intact
connexin43 is required to enhance signaling and gene expression in
osteoblast-like cells. J Cell Biochem. 114:2542–2550. 2013.
View Article : Google Scholar : PubMed/NCBI
|
